Tyrosine Kinase Inhibitors, Pancreatic Hyperenzymemia and Acute Pancreatitis: A Review

E-ISSN： 2212-2710|5|2|165-168

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.5, Iss.2, 2011-05, pp. : 165-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The 2010 Patent Landscape for Spleen Tyrosine Kinase Inhibitors+

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 2, 2012-01 ,pp. : 97-120

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant Treatment for Acute Pancreatitis

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 8, Iss. 2, 2014-05 ,pp. : 154-161

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Inventions on Receptor Tyrosine Kinase RET Modulation

Recent Patents on Biotechnology, Vol. 2, Iss. 1, 2008-01 ,pp. : 47-54

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 89-98

Bentham Science Publishers

Access to resources Recommend Favorite

The Regulatory Roles of Mitogen-Activated Protein Kinase (MAPK) Pathways in Health and Diabetes: Lessons Learned from the Pancreatic #946;-Cell

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 10, Iss. 2, 2017-05 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite